MianowskaB, FendlerW, TomasikB, et al.: Brief report: Effect of insulin dilution on lowering glycemic variability in pump-treated young children with inadequately controlled type 1 diabetes. Diabetes Technol Ther, 2015; 17:605–610.
2.
American Diabetes Association: History of Diabetes. www.diabetes.org/research-and-practice/student-resources/history-of-diabetes.html (accessed August4, 2015).
3.
SegalAR, SayedNE: Are you ready for more insulin concentrations?. J Diabetes Sci Technol, 2015; 9:331–338.
4.
WoodJR, MillerKM, MaahsDM, et al.: Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care, 2013; 36:2035–2037.
5.
ChaseHP, MaahsDM: Understanding Diabetes; A Handbook for People Who Are Living with Diabetes, 13th ed. Denver: Children's Diabetes Foundation at Denver, 2015.
6.
LauYN, KorulaS, ChanAK, et al.: Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes, 2015May22 [Epub ahead of print]. doi: 10.1111/pedi.12285.
7.
DavisEA, KeatingB, ByrneGC, et al.: Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care, 1997; 20:22–25.
8.
GnanalinghamM, NewlandP, SmithC: Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child, 1998; 79:59–62.
9.
LteifAN, SchwenkWF: Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care, 1999; 22:137–140.
10.
Abul-AinineAA, Abul-AinineSA. Toddlers' diabetes: the lost insulin drop and SemiPens vs. DeciPen. Pediatr Diabetes, 2014; 15:319–323.
11.
KeithK, NicholsonD, RogersD: Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr, 2004; 43:69–74.
12.
OlsenBS, LilleøreSK, KorsholmCN, et al.: Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals. J Diabetes Sci Technol, 2010; 4:1468–1475.
13.
ClarkPE, OkenfussCR, CampbellM: Half-unit dose accuracy with HumaPen® Luxura™ HD: an insulin pen for patients who need precise dosing. J Diabetes Sci Technol, 2010; 4:353–356.
14.
BlackmanSM, RaghinaruD, AdiS, et al.: Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes, 2014; 15:564–572.
15.
BerghaeuserM, KapellenT, HeidtmannB, et al.: Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes, 2008; 9:590–595.
16.
ElleriD, AllenJM, TauschmannM, et al.: Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength. BMJ Open Diabetes Res Care, 2014; 2(1):e000040.
17.
CerielloA, KilpatrickES: Glycemic variability: both sides of the story. Diabetes Care, 2013; 36(Suppl 2):S272–S275.
18.
Barnea-GoralyN, RamanM, MazaikaP, et al.: Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care, 2014; 37:332–340.
19.
StickelmeyerMP, GrafCJ, FrankBH, et al.: Stability of U-10 and U-50 dilutions of insulin lispro. Diabetes Technol Ther, 2000; 2:61–66.
20.
Concentrated insulin glargine (Toujeo) for diabetes. Med Lett Drugs Ther, 2015; 57:69–70.
21.
De la PeñaA, RiddleM, MorrowLA, et al.: Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects. Diabetes Care, 2011; 34:2496–2501.
22.
RuanY, ElleriD, AllenJM, et al.: Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial. Diabetologia, 2014; 58:687–690.
